Can Fite Biofarma FY GAAP EPS $(0.01), Same YoY, Sales $743.00K Down From $810.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Can Fite Biofarma (AMEX:CANF) reported its FY GAAP EPS at $(0.01), unchanged YoY, with sales of $743.00K, down 8.27% from $810.00K YoY.
March 28, 2024 | 11:23 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Can Fite Biofarma reported unchanged yearly EPS at $(0.01) and a sales decrease of 8.27% to $743K.
The unchanged EPS indicates stability in Can Fite Biofarma's profitability, but the decrease in sales by 8.27% YoY could concern investors about the company's growth prospects, potentially leading to a negative short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100